This report describes the effect of the dissociative anaesthetic ketamine, a non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor, on the infectivity of the neurotropic rabies virus, in neuronal culture systems and in vivo. Ketamine (1-2mM) produced an approximate 10Q-1000-fold decrease in the production of rabies virus in neuronal cell cultures. Rabies virus infection was also inhibited in non-neuronal cell lines (Baby Hamster Kidney fibroblasts) but the inhibitory effects appeared better expressed in cells of neuronal origin (neuroblastoma and primary neuronal cultures). The kalnate/quisqualate competitive antagonist CNQX did not modify the course of rabies virus infection and modulators of known NMDA regulatory sites (Mg 2 + , Zn 2 + , HA-966) failed to antagonize the ketamine-rnediated inhibition of rabies virus production in neuroblastoma cells. Furthermore, Ca 2 +-mobilization does not appear to be involved because Ca 2 +-depleted and EGTA-treated medium did not affect the normal production of rabies virus. The action of ketamine on rabies virus infection in vivo was also investigated; peripheral treatment ofrats with this drug inhibited rabies virus infection in the thalamus, cortex and hippocampal formation (in particular the pyramidal layer of the CA1 region). Taken together, these data suggest that the ketamine-mediated inhibition of rabies virus production in vitro, although highly selective, is not acting via classic NMDA receptor-mediated mechanisms. However, the ketaminemediated retardation of rabies virus infection in vivo may offer new prospects for post-exposure rabies antiviral therapy.
Introduction
Rabies virus, a member of the Rhabdoviridae, is an enveloped, bullet-shaped virus, containing a non-seq-mented negatively stranded RNA genome (reviewed by Tordo and Poch, 1988) . It is highly neurotropic (Tsiang et al., 1983) and produces only mild histopathological lesions (Murphy, 1977) , despite the dramatic clinical manifestations of neurological dysfunctioning (Johnson, 1965) . Consequently, the neuronal pathogenic mechanism is suspected of being related to viral-induced defects in neuroreceptor function regulation (KosChel and Halback, 1979; Tsiang, 1982) . Indeed it appears that during rabies virus infection the integrative functions which modulate the sleep and waking stages are disorganized, and epileptic patterns and myoclonus are observed (Gourmelon et al., 1986) . Furthermore, persistant infections of rabies virus in neuronal cell lines causes a total loss of opiate receptor function (Munzel and Koschel, 1981) via an uncoupling of the opiate receptor from the inhibitory regulatory protein N; (Koschel and Munzel 1984) .
It is now generally accepted that the major excitatory neurotransmitters in the central nervous system are the endogenous amino acids, L-glutamate and L-aspartate, acting notably at the N-methyl-D-aspartate (NMDA) receptor (Cotman et al., 1987) . Although the mechanism of rabies virus lethality is unknown, the finding that selective brain function alterations occur, points to a virus-induced dysfunctioning of the NMDA receptor as a possible mechanism of rabies virus pathogenesis. This view is supported by a growing body of evidence showing that neurotoxicity is related to the excitatory effects of endogenous amino acids, on NMDA receptors (Rothman and Olney, 1987; Choi, 1987) . The neurotoxic effect of these amino acids are now recognized as a major factor contributing to several neuropathological events, including ischemia (Simon et aI., 1984) , epilepsy (Dingledine et al., 1990) and the neurodegenerative disorders Huntington's Chorea and Alzheimer's disease (Greenamyre et aI., 1985) .
Because the excitotoxic amino acids are involved in many diseases of the central nervous system, it seems plausible that pharmacological intervention, aimed at regulating viral-induced brain dysfunctions, could be an effective form of post-exposure anti-rabies therapy. Several non-competitive NMDA antagonists, such as MK-801, phencyclidine and ketamine, can act as anticonvulsants (Leycesse et aI., 1986; Wong et al., 1986; Nevins and Arnolde, 1989) and protect against experimentally induced ischaemic-hypoxia injury {MacDonald et aI.,
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).Consequently we have attempted to establish if the dissociative anaesthetic ketamine could modify the development of rabies virus infection, in neuronal culture systems and in vivo, via its selective interaction' with the NMDA receptor. Fig. 1 . Dose-dependent inhibition of rabies virus production by ketamine in neuronal cell lines. Primary cortical neurones (.") and human neuroblastoma cells (e) were infected for 1 h with fixed rabies virus CVS strain (4.6 x 10 6 PFUml-1 ) ; the viral inoculum was removed and the cells washed with fresh medium. Infected monolayers were treated with prewarmed medium containing different concentrations of ketamine. Three days after infection the supernatants from infected cultures were titred for the presence of infectious virus.
A significant inhibition of rabies virus production (100-1OOO~fold) was obtained with between 1 and 2 mM ketamine for both rat primary cortical neurones and human neuroblastoma cells ( Fig. 1) . However, the level of inhibition decreased at lower ketamine concentrations, until no significant effect was observed below 0.2 mM ketamine. The antiviral activity of ketamine was not the result of a druq-lnduced cytopathic effect, as assessed by trypan blue dye exclusion, or to a direct virucidal effect (data not shown). The addition of ketamine (2mM) after the viral adsorption step was sufficient to inhibit the release of virus in rat primary cortical neurones, approximately 500-fold, up to 4 days post-infection (p.i.) ( Fig. 2) . To assess the effect of ketamine on the kinetics of virus production in other neuronal and non-neuronal cell lines, comparative assays in BHK and human neuroblastoma (IMR-32) were performed (Fig. 2 ). Administration of ketamine after the viral inoculation step inhibited the production of infectious virus in all the tested cell lines. However, a significant recovery from the inhibitory effect of ketamine was observed in non-neuronal cultures compared to neuronal cell lines.
To evaluate the potential modulatory effect of extracellular calcium on the ketamine-mediated inhibition of rabies virus replication, the kinetics of virus production was determined in calcium-depleted and EGTA-treated medium. The results in Fig.3 show that a Ca 2 +-depleted medium (0.37mM Ca 2 +) with or without EGTA (0.25mM) did not significantly change the normal range of virus production.
In order to assess whether the inhibition of virus production by ketamine was mediated via a selective NMDA-receptor mechanism, we attempted to modify the course of rabies virus infection using CNQX, the potent competitive kainate/quisqualate (NMDA-related) receptor antagonist. No significant inhibition in the production of rabies virus between 0.125 and 1.0 mM CNQX was observed, despite a 100-fold decrease in viral titres with 1 mMketamine (Fig.4a ). Furthermore, the addition of 1mM CNQXfailed to modify the kinetics of virus production over 4 days compared to untreated controls (Fig. 4b) .
We further characterized the ketamine-mediated inhibition of rabies virus infection by attempting to modify the inhibitory effect of ketamine with other classes of noncompetitive NMDA antagonists. An approximate 30-fold increase in the extracellular concentration of Mg 2 + , a non-competitive NMDA antagonist (Nowak et sl., 1984) , failed to significantly alter the normal production or the ketamine-mediated inhibition of rabies virus (Fig. 5 ). Similarily, when the concentration of Zn 2 + , an NMDA receptor modulator (Peters et al., 1987) , was increased from 0.1 J.LM to 50 J.LM no change in the production of rabies or the inhibition of virus release by ketamine was observed 0.030.060.1250.250.5 1.0 2.0
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The high antiviral effect of ketamine, a non-competitive antagonist for the NMDA receptor which acts by blocking the NMDA-associated ion channel (MacDonald and Nowak, 1990) suggested an eventual role of this receptor complex in the pathogenesis of rabies virus. A major contributing factor to the excitotoxic hypothesis of cell death is the excessive ion channel-mediated intracellular accumulation of Ca 2 + via activation of the NMDA agonist site (Meldrum et al., 1985; Choi, 1988) . The subsequent induction and/or subversion of important cellular functions of Ca 2 +-dependent enzymes results in neurotoxicity and neuronal death (Rothman and Olney, 1987) . However, it is unlikely that a related rabies virus-induced accumulation of cytosolic Ca 2 + is responsible for the observed neurological dysfunctions because in calcium-deficient Discussion dal cells of the CA1 section of the hippocampus, was observed ( Fig. 7b ), despite the obvious presence of virus in the cortex. rabies virus CVS strain (4.6 x 10 6 PFU rnr') for 1h at 37°C. The viral inoculum was removed, cells were washed in fresh medium (Modified Eagles medium without Ca 2 + + 10% FCS), and prewarmed medium was then added, containing; untreated (A); 0.25mM EGTA (6); 1.5mM ketamine (e). Culture supernatants were sampled daily, up to 4 days, and assayed for infectious virus by plaque titration.
( Fig. 5b ). Furthermore, the non-competitive NMDA antagonist, HA-966, which competes with glycine for the glycine modulation site of the NMDA receptor (Foster and Kemp, 1989) , failed to inhibit the normal production or antagonize the ketamine-mediated inhibition of rabies virus between 0.1 fLM-1 00 fLM (Fig. 5c) .
In vivo, the dissemination of rabies virus throughout the different brain structures of placebo-control and ketamine-treated rats, was monitored by direct immunofluorescence. On Day 4 p.i., most brain structures were infected in the controls: striatum, thalamus, cortex, cerebellum and hippocampus (Fig. 6a ). In the CA1 region of the hippocampus, a high density of viral inclusions could be detected (Fig. 7a) . In ketamine-treated rats, inhibition of rabies virus infection in most brain areas was observed at this stage, but a significant decrease in the degree of infection can be observed in the thalamus and cortex (Fig. 6b ). The level of inhibition was particularly pronounced in the hippocampal formation, where an almost total absence of infected cells, notably the pyrami- (0). Three days later culture supernatants were sampled and titred for infectious virus. (b) Unadsorbed virus was removed by washing and 2 ml of medium was added, containing: untreated (A); 1mM CNQX (e); 1mM ketamine (0). The supernatants were sampled daily, up to 4 days, and assayed for the presence of infectious virus by plaque titration. Fig. 5 . Characterisation of the ketamine-mediated inhibition of rabies virus production. Human neuroblastoma (IMR-32) cells (3 x 10 5/Petri dish) were infected with CVS rabies strain (4.6 x 10 6 PFU rnl") for 1 h at 37"C. ketamlne-treated rat brains on Day 4 post-infection, after stereotaxic inoculation of CVS rabies strain (1 fLl; 10 5 PFU) into the right striatum (arrowed). Ketamine (15 mg) was then inoculated intra-peritoneally twice daily. Brain sections correspond to the A4110 level from the brain atlas of Konig and Klippel (1967) . The fluorescent viral inclusions are presented schematically by black dots and are expressed as an average observation from six placebo control and 10 ketamine-treated rat brains. medium we could observe no reduction of rabies virus infection in neuronal cells. Concordantly, an inhibition of Ca 2 + influx by ketamine is probably not the mechanism for impairment of rabies virus replication. Several additional arguments, based on the antiviral action of ketamine, were against any specific interaction between rabies virus and the high-affinity NMDA receptor binding sites. Firstly, because BHK cells are not believed to contain NMDA receptors, the reason for the level of inhibition (approximately 50-fold) observed on treatment of such cells with ketamine is not clear. However, it may simply represent a possible ketamine-mediated competitive interference with sensitive membrane proteins and lipids, often primary targets of anaesthetic action (Tas et a/., 1987) . Secondly, since the specific activity of ketamine is in the micromolar range, the high concentrations (1-2 mM) required to achieve an efficient antiviral effect could not exclude a possible non-NMDA receptormediated action of this drug. Thirdly, comparative assays with three different classes of NMDA non-competitive antagonist, HA-966, Mg 2 + and Zn 2 + , showed no significant inhibition in the normal kinetics, or modification in the ketamine-mediated inhibition, of rabies virus infection. Fourthly, treatment with an NMDA competitive antagonist (AP-5), did not modify the production of rabies virus in cortical neurones compared to controls (Tsiang et al., 1991) . Consequently, these data tend to eliminate any mechanism operating through NMDA receptor highaffinity binding sites.
A report by Rothman and Olney (1987) has shown that high concentrations of ketamine (3mM), can partially protect against kainate-induced neurotoxicity in ex vivo chick embryo retina, and suggests non-specific interactions with NMDA-related receptor subtypes can occur at elevated concentrations of the non-competitive NMDA antagonists. However, CNQX, a competitive antagonist of the NMDA-related kainate and quisqualate receptors, did not inhibit the production of rabies virus, suggesting that the action of ketamine was not occurring via an association with these receptor subtypes. Although we have not tested antagonists of the other characterized NMDArelated receptors, L-AP4 and metabotropic, there are no known reports of any specific interaction between ketamine and these receptors (Watkins et al., 1990) . However, one cannot rule out the possibility of ketamine acting at additional neurotransmitter receptors. There are several reports that ketamine can block the ion channel of the nicotinic acetylcholine receptor (Aronstam et al., 1982; Takara et al., 1986) , interact with the sigma-opioid receptors (Parsons et al., 1981) and can affect the dopaminergic system (Rao et al., 1989) .
In the light of these observations the significance of the decrease in the number of rabies virus-infected cells in ketamine-treated rat brain, in particular the CA1 region of the hippocampus, is not understood. However, NMDA receptor binding has been demonstrated for a variety of brain structures, but the CA1 areas from the hippocampal formation seem to have a particularly high receptor density (Cotman et al., 1987) . Several reports have demonstrated that the CA1 pyramidal cells are extremely sensitive to neuronal loss following ischemia and that this phenomena involves NMDA receptors (Simon et al., 1984) . Since NMDA receptors appear to mediate excitotoxicity, it is significant that there appears to be a tentative juxtaposition between NMDA receptor distribution and regions .. '::.'. ketamine-treated rat brain on Day 4 postinfection after stereotaxic inoculation of rabies strain CVS (1 iLl; 10 5PFU) into the right striatum. Ketamine (15mg) was injected intraperitoneally twice daily. Viral inclusions were detected by direct immunofluorescence of rat brain cryosections representing the level A411 0 from the brain atlas of Konig and Kippel (1967) . Abbreviations: C, cortex; H, hippocampal formation (CA1 region) x 315. sensitive to rabies virus infection. Further studies are needed to correlate the ketamine-mediated protection of rabies-free brain structures with the distribution of excitatory amino acid binding sites.
The ketamine-mediated inhibition of rabies virus infection is highly selective, only the non-competitive NMDA antagonists binding to the phencyclidine site are active, as we have shown that other antagonists of this class, MK-801 and various phencyclidine derivatives, are equally efficient antivirals in cultured neuroblastoma and primary cortical neurones (H. Tsiang, unpublished data) . The anti-convulsant and neuroprotective action of this class of non-competitive NMDA anatagonists in experimental models of epilepsy and their ability to rapidly cross the blood-brain barrier emphasizes a major therapeutic potential for these drugs in the treatment of viral-induced neurological disorders. Although the ketamine-mediated inhibition of rabies infection is probably occurring via a non-NMDA receptor mechanism our data offers new avenues for post-exposure treatment of the highly neurotropic rabies virus with this class of non-competitive NMDA antagonist.
Materials and Experimental procedures
Titration of viral infectivity
Challenge virus strain (CV8)-fixed rabies virus, adapted to BHK (Baby Hamster Kidney) fibroblasts, was prepared as previously described (Tsiang et el., 1983) . The release of infectious virus into the culture medium, from infected cell lines, was titred by an in vitro plaque assay using Chicken Embryo Related (CER)cells, as described by Smith et al. (1977) .
Cell cultures
Cortical neurones was prepared from 14-day-old rat embryos. The cortex was dissected under a binocular microscope and mechanically dissociated by repeated transfer through Pasteur pipettes. Cells were seeded into 35 mm poly-L-ornithine (2IJ.g/ml) (Sigma Chemical Co., St Louis, MO)-coated Petri dishes (Falcon, Becton-Dickinson, Grenoble, France) in the presence of F-10 medium (Boehringer, Mannheim, Germany) supplemented with 7.5% foetal calf serum and 7.5% horse serum and nerve growth factor (5IU/ml; Collaborative Research Inc., Lexington, MA). Two days later the cells were treated with cytosine arabinoside (2.8 fL9 mr ": Sigma) for 24-h, to inhibit the growth of non-neuronal cells.
The human neuroblastoma cell line (IMR-32) obtained from Professor K. Yamanouchi (Tokyo, Japan), was maintained in F-10 medium containing 10% calf serum. BHK and CER fibroblasts were maintained in Eagles' medium (MEM; Gibco Ltd, Middlesex, U.K.) supplemented with 0.3% tryptose, 10% foetal calf serum, penicillin (100IU rnr") and streptomycin (100 fL9 ml"). Cell cultures were prepared in 35 mm plastic Petri dishes (Falcon).
Antagonists
NMDA non-competitive (phencyclidine site) ketamine (2 -(2-chlorophenyl)-(methylamino)-cyclohexanone); NMDA non-competitive (glycine site), HA-966 (3-amino-1-hydroxy-2-pyrrolidone); and the quisqualate/kainate competitive antagonist, CNQX (6cyano-Z-nltroquinoxaline-Z, 3-dione), were purchased from Research biochemicals Inc. (Natwick, MA). Ketamine was also obtained from IFFA-Credo (Rh6ne-Merieux, Lyon, France) or was a generous gift from Dr J.M. Kamenka (Montpellier, France). The same drug, from different origins, had identical properties in preliminary comparative studies. The selected concentrations of antagonists caused no detectable toxic effect for any of the cell lines and contained no direct virucidal effect for up to 5 days.
Stereotaxic inoculation
Male Wistar rats (approximately 250g) were anaesthesized by intramuscular administration of a mixture of Imalgene (25mg rat-1 ) and Vetranquil (0.75 mg rat-1 ) in phosphate-buffered saline (PBS) before viral inoculation. The anaesthesized rats were placed in a stereotaxic bench and the viral inoculum (CVS, rabies strain) (1ul; 10 5MICLD 5 0 ) injected into the right side of the striatum using a Hamilton syringe, at the level corresponding to A6860, according to the brain atlas of Konig and Klippel (1967) , as previously described (Ceccaldi et al., 1989) . After viral inoculation, 10 rats were treated every 12 h by an intra-peritoneal injection of 15 mg of ketamine; anaesthesia was observed after each injection. Six placebo control rats were treated, every 12 h after virus inoculation, with an intra-peritoneal injection of PBS.
Immunofluorescence of rabies-infected rat brain
Cryosections from rabies-infected rat brain were prepared as previously described (Ceccaldi et al., 1989) and stained with a rabbit anti-rabies nucleocapsid IgG conjugated with fluorescein isothiocyanate (Pasteur Diagnostics, France) by the method of Atanasiu (1974) .Sections were viewed with a Zeiss IM32 inverted microscope fitted with a type-IV F1 epifluorescence condenser, containing the standard FITC filter set, in addition to a hlqh-sensltivity video camera (Lhesa, France).
